Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ICO.STthis companyIconovo AB (publ)	SEK 1.10	-1×	0.37×	39.24×	-1.23×	-96.0%	-3959.5%	-3959.5%	-3924.3%	-36.8%	-36.0%	-106.0%	0.04×	0.05×	-97.45×	1.01×	0.0%	4	4.35	2	C+
ACTI.STActive Biotech AB	SEK 3.44	-166.06×	111.47×	0×	-170.4×	-98.9%	0.0%	0.0%	0.0%	-67.1%	-65.6%	-0.5%	0.03×	1.76×	0×	4.66×	0.0%	3	4.44	2	C+
ARCOMA.STArcoma AB	SEK 8.50	20.97×	1.41×	0.8×	4.36×	-14.6%	5.2%	6.6%	3.8%	6.7%	9.3%	12.5%	0×	-2.2×	73.58×	3.49×	0.0%	6	6.68	3	B+
BIOVIC-B.STBiovica International AB (publ)	SEK 0.31	-1.17×	0.95×	6.14×	-0.26×	-1052.3%	-523.5%	-523.5%	-522.1%	-80.9%	-76.5%	-77.0%	0.05×	1.07×	-176.89×	4.3×	0.0%	3	-9.24	2	C
HEART.STScandinavian Real Heart AB (Publ)	SEK 16.05	-1.96×	1.11×	0×	-3.8×	-85.9%	0.0%	0.0%	0.0%	-56.8%	-22.9%	-23.8%	0.07×	0.8×	-41.14×	2.5×	0.0%	3	8.38	2	C
IDLDX.STIDL Diagnostics AB (publ)	SEK 0.32	-6.7×	0.55×	1.53×	-7.18×	-1307.2%	52.2%	-20.2%	-22.9%	-8.2%	-6.6%	-11.3%	0.09×	2.89×	-24.09×	3.21×	0.0%	3	0.24	4	A
Peer median	—	-1.96×	1.11×	0.8×	-3.8×	-98.9%	0.0%	0.0%	0.0%	-56.8%	-22.9%	-11.3%	0.05×	1.07×	-24.09×	3.49×	0.0%	3	4.44	2	—